Top Pharmaceuticals stocks in Australasia
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CSLCSL | AU$133.24bn | 34.18 | 1.42% |
EBOEBOS | NZ$6.91bn | 22.86 | 3.22% |
NEUNeuren Pharmaceuticals | AU$2.51bn | 15.94 | n/a |
SIGSigma Healthcare | AU$2.03bn | 305.42 | 0.76% |
CUVClinuvel Pharmaceuticals | AU$744.89m | 24.65 | 0.34% |
MYXMayne Pharma | AU$598.78m | n/a | n/a |
BOTBotanix Pharmaceuticals | AU$386.79m | n/a | n/a |
AFTAFT Pharmaceuticals | NZ$314.60m | 28.55 | 0.25% |
PBPProbiotec | AU$230.15m | 25.32 | 2.47% |
RCERecce Pharmaceuticals | AU$130.37m | n/a | n/a |
VLSVita Life Sciences | AU$127.46m | 13.62 | 3.98% |
NXSNext Science | AU$96.26m | n/a | n/a |
PAAPharmaust | AU$82.29m | n/a | n/a |
VITVitura Health | AU$71.98m | 7.59 | 8% |
IHLIncannex Healthcare | AU$65.07m | n/a | n/a |
BIOBiome Australia | AU$59.36m | n/a | n/a |
SPLStarpharma Holdings | AU$49.42m | n/a | n/a |
MVPMedical Developments International | AU$40.56m | n/a | n/a |
LGPLittle Green Pharma | AU$39.01m | n/a | n/a |
IMCImmuron | AU$22.78m | n/a | n/a |